These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6317844)

  • 1. Central alpha receptors and their role in digoxin cardiotoxicity.
    Plunkett LM; Tackett RL
    J Pharmacol Exp Ther; 1983 Dec; 227(3):683-6. PubMed ID: 6317844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of central beta-receptor antagonism on digoxin cardiotoxicity.
    Plunkett LM; Tackett RL
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):209-20. PubMed ID: 2862669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
    Kawasaki H; Takasaki K
    J Pharmacol Exp Ther; 1986 Mar; 236(3):810-8. PubMed ID: 3005557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of coronary alpha 1-adrenoceptors of the dog heart in dopamine-induced cardiostimulation evidenced by treatment with prazosin.
    Kékesi V; Rabloczky G; Mader MR; Juhász-Nagy A
    Acta Physiol Hung; 1989; 73(1):61-9. PubMed ID: 2540619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the arrhythmogenic dose of epinephrine after adrenergic receptor blockade with prazosin, metoprolol, or yohimbine in halothane-xylazine-anesthetized dogs.
    Tranquilli WJ; Thurmon JC; Benson GJ
    Am J Vet Res; 1986 Jan; 47(1):114-8. PubMed ID: 3946887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the toxic to inotropic dose ratio of digoxin by excluding central nervous system influences on the heart.
    Pace DG; Gillis RA
    Arch Int Pharmacodyn Ther; 1982 Jan; 255(1):103-16. PubMed ID: 7073395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiac beta-adrenergic blockade or denervation on cardiotoxicity of digoxin and an aminosugar cardenolide.
    Puryear SK; Nash CB; Caldwell RW
    J Cardiovasc Pharmacol; 1981; 3(1):113-27. PubMed ID: 6160341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of cocaine: enhancement by yohimbine and atropine.
    Wilkerson RD
    J Pharmacol Exp Ther; 1989 Jan; 248(1):57-61. PubMed ID: 2913288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential blocking effects of prazosin and yohimbine on vasopressor responses to sympathetic nerve stimulation and intravenous norepinephrine in the pithed rat.
    Lee JY; Walsh GM; Heilman RD; Radzialowski FM
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):97-112. PubMed ID: 6322258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of central alpha 1- and alpha 2-adrenoceptors in the regulation of vasopressin release and the cardiovascular system.
    Kimura T; Shoji M; Iitake K; Ota K; Matsui K; Yoshinaga K
    Endocrinology; 1984 Apr; 114(4):1426-32. PubMed ID: 6323145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inotropic actions of N-acetylprocainamide: blockade and reversal by propranolol.
    Lertora JJ; King LW; Donkor KA
    Angiology; 1986 Dec; 37(12 Pt 2):939-49. PubMed ID: 2433968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone-induced potentiation of cardiac alpha-2 adrenoceptor-mediated depression of neurogenic tachycardia.
    Slavik KJ; Szilagyi JE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):184-91. PubMed ID: 8101216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs.
    Sudoh K; Tanaka H; Inagaki O; Asano M; Takenaka T
    J Auton Pharmacol; 1996 Jun; 16(3):147-54. PubMed ID: 8884461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of digoxin toxicity by 6-hydroxydopamine and soironolactone.
    Anders JC; Crisona FJ; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):459-72. PubMed ID: 7423022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.